Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 191,866
  • Shares Outstanding, K 89,240
  • Annual Sales, $ 72,760 K
  • Annual Income, $ 35,340 K
  • EBIT $ 31 M
  • EBITDA $ 31 M
  • 60-Month Beta 2.89
  • Price/Sales 2.89
  • Price/Cash Flow 5.25
  • Price/Book 1.81

Options Overview Details

View History
  • Implied Volatility 151.74% (-37.23%)
  • Historical Volatility 89.61%
  • IV Percentile 29%
  • IV Rank 22.84%
  • IV High 664.40% on 09/19/25
  • IV Low 0.01% on 09/08/25
  • Expected Move (DTE 9) 0.40 (17.83%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 40
  • Volume Avg (30-Day) 81
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 3,952
  • Open Int (30-Day) 3,692
  • Expected Range 1.84 to 2.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.08
  • Number of Estimates 4
  • High Estimate -0.06
  • Low Estimate -0.09
  • Prior Year -0.08
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.63 +37.43%
on 02/12/26
2.31 -3.03%
on 03/03/26
+0.48 (+27.27%)
since 02/10/26
3-Month
1.43 +56.64%
on 12/30/25
2.38 -5.88%
on 01/16/26
+0.61 (+37.42%)
since 12/10/25
52-Week
1.13 +98.23%
on 04/09/25
2.38 -5.88%
on 01/16/26
+0.65 (+40.88%)
since 03/10/25

Most Recent Stories

More News
Compugen: Q4 Earnings Snapshot

Compugen: Q4 Earnings Snapshot

CGEN : 2.24 (+4.19%)
Compugen Reports Fourth Quarter and Full Year 2025 Results

HOLON, ISRAEL , March 2, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by...

CGEN : 2.24 (+4.19%)
Compugen to Participate in Upcoming Investor Conferences

HOLON, Israel , Feb. 19, 2026 /PRNewswire/ -- Compugen Ltd.  (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 2.24 (+4.19%)
Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026

HOLON, Israel , Feb. 17, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 2.24 (+4.19%)
Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

HOLON, Israel , Feb. 12, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 2.24 (+4.19%)
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million

HOLON, Israel , Dec. 17, 2025 /PRNewswire/ --  Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 2.24 (+4.19%)
Compugen: Q3 Earnings Snapshot

Compugen: Q3 Earnings Snapshot

CGEN : 2.24 (+4.19%)
Compugen Reports Third Quarter 2025 Results

HOLON, Israel , Nov. 10, 2025 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 2.24 (+4.19%)
Compugen to Participate in Stifel 2025 Healthcare Conference

HOLON, Israel , Nov. 4, 2025 /PRNewswire/ --  Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 2.24 (+4.19%)
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025

HOLON, Israel , Oct. 27, 2025 /PRNewswire/ --  Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 2.24 (+4.19%)

Business Summary

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas...

See More

Key Turning Points

3rd Resistance Point 2.42
2nd Resistance Point 2.33
1st Resistance Point 2.29
Last Price 2.24
1st Support Level 2.15
2nd Support Level 2.06
3rd Support Level 2.02

See More

52-Week High 2.38
Last Price 2.24
Fibonacci 61.8% 1.90
Fibonacci 50% 1.76
Fibonacci 38.2% 1.61
52-Week Low 1.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar